Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ADC THERAPEUTICS SA

(ADCT)
  Report
Delayed Nyse  -  04:00:02 2023-02-07 pm EST
4.530 USD   -0.66%
02/06Adc Therapeutics : Biopôle Route de la Corniche 3B 1066 Epalinges Switzerland - Form 6-K
PU
02/02ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder
BU
02/01ADC Therapeutics to Participate in February Investor Conferences
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
ETFs positioned on ADC THERAPEUTICS SAETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Direxion Fallen Knives ETF - USD0.46%-9.78%-NC
ALPS Medical Breakthroughs ETF - USD0.37%2.19%United_States
IShares Biotechnology ETF - USD0.02%0.60%-NC
BMO MSCI Genomic Innovation Index ETF - CAD0.02%1.73%-NC



Copyright ę 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ôInformationö) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart ADC THERAPEUTICS SA
Duration : Period :
ADC Therapeutics SA Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 4,53 $
Average target price 13,14 $
Spread / Average Target 190%
Chart ADC THERAPEUTICS SA
Duration : Period :
ADC Therapeutics SA Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
ADC THERAPEUTICS SA17.97%365
REGENERON PHARMACEUTICALS, INC.6.72%83 397
VERTEX PHARMACEUTICALS5.57%78 258
WUXI APPTEC CO., LTD.13.21%39 435
BIONTECH SE-6.16%34 256
BEIGENE, LTD.11.48%25 531